Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Jul;64(7):1062-1067.
doi: 10.1007/s11427-020-1893-9. Epub 2021 Feb 4.

Making sense of spike D614G in SARS-CoV-2 transmission

Aria C Shi  1 , Xuping Xie  2
Affiliations
Review

Making sense of spike D614G in SARS-CoV-2 transmission

Aria C Shi et al. Sci China Life Sci. 2021 Jul.

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the etiologic agent of the current coronavirus disease 2019 (COVID-19) pandemic, has evolved to adapt to human host and transmission over the past 12 months. One prominent adaptive mutation is the asparagine-to-glycine substitution at amino acid position 614 in the viral spike protein (D614G), which has become dominant in the currently circulating virus strains. Since spike protein determines host ranges, tissue tropism, and pathogenesis through binding to the cellular receptor of angiotensin converting enzyme 2 (ACE2), the D614G mutation is hypothesized to enhance viral fitness in human host, leading to increased transmission during the global pandemic. Here we summarize the recent progress on the role of the D614G mutation in viral replication, pathogenesis, transmission, and vaccine and therapeutic antibody development. These findings underscore the importance in closely monitoring viral evolution and defining their functions to ensure countermeasure efficacy against newly emerging variants.

Keywords: COVID-19; D614G; SARS-CoV-2.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Chan, J.F.W., Zhang, A.J., Yuan, S., Poon, V.K.M., Chan, C.C.S., Lee, A.C. Y., Chan, W. M., Fan, Z., Tsoi, H. W., Wen, L., et al. (2020). Simulation of the clinical and pathological manifestations of coronavirus disease 2019 (COVID-19) in a Golden Syrian Hamster Model: implications for disease pathogenesis and transmissibility. Clin Infect Dis, doi: 10.1093/cid/ciaa325. - PMC - PubMed
    1. Dai, L., and Gao, G.F. (2020). Viral targets for vaccines against COVID-19. Nat Rev Immunol, doi: 10.1038/s41577-020-00480-0. - PMC - PubMed
    1. Daniloski, Z., Guo, X., and Sanjana, N.E. (2020). The D614G mutation in SARS-CoV-2 Spike increases transduction of multiple human cell types. bioRxiv, doi: 10.1101/2020.06.14.151357. - PMC - PubMed
    1. Davies, N.G., Barnard, R.C., Jarvis, C.I., Kucharski, A.J., Munday, J., Pearson, C.A.B., Russell, T.W., Tully, D.C., Abbott, S., Gimma, A., et al. (2020). Estimated transmissibility and severity of novel SARS-CoV-2 Variant of Concern 202012/01 in England. medRxiv, doi: 10.1101/2020.12.24.20248822.
    1. Hou, Y.J., Chiba, S., Halfmann, P., Ehre, C., Kuroda, M., Dinnon Iii, K.H., Leist, S.R., Schäfer, A., Nakajima, N., Takahashi, K., et al. (2020a). SARS-CoV-2 D614G variant exhibits efficient replication ex vivo and transmission in vivo. Science eabe8499. - PMC - PubMed

Substances